Comparison of outcomes after DA ‐ EPOCH ‐R or GMALL high‐intensity therapy for front‐line treatment of Burkitt lymphoma: A retrospective cohort

2026/07/25 by Eduard Schulz, Florian Posch, Kristina Friedrich +2

paper · doi:10.1111/bjh.70730